Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Third COVID-19 vaccine dose effectively boosts immunity for the majority of patients with cancer

Nearly 100% of cancer patients with solid tumours have antibodies effective against the Delta variant after a third dose of COVID-19 vaccine, according to new results published in Cancer Cell.
23 Dec 2021
United Kingdom
Research buzz

To view this News Article please log in or create a profile

Similar stories

Tateossian, H. and Southern, A. et al. eLife

Researchers at the Crick, MRC Harwell Institute and UCL Queen Square Institute of Neurology have identified the genetic cause for the most common type of hearing loss in children w… More...

Colleagues have generated human stem cell models which, for the first time, contain notochord – a tissue in the developi… More...

Waves of human migration across Europe during the first millennium AD have been revealed using a more precise method of … More...

Researchers from the Crick and UCL, working with Genomics England, have shown that rogue genetic material called extrach… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk